Miraba Tablet contains Mirogabalin Besylate 5 mg, a novel gabapentinoid used for the treatment of neuropathic pain. Mirogabalin is structurally related to gabapentin and pregabalin but is designed to provide more selective binding to the α2δ-1 subunit of voltage-gated calcium channels, resulting in effective pain relief with a potentially improved side-effect profile.
This medication is primarily indicated for patients suffering from peripheral neuropathic pain, including conditions such as diabetic neuropathy, post-herpetic neuralgia, and other nerve injury-related pain syndromes. By targeting nerve overactivity, Miraba helps reduce abnormal pain signals, improving quality of life and daily functioning.
রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন
Miraba Tablet 5 mg is indicated for:
Peripheral neuropathic pain in adults
Diabetic peripheral neuropathic pain (DPN)
Post-herpetic neuralgia (PHN)
Chronic neuropathic pain associated with nerve injury
This medication is particularly suited for patients who require long-term pain management with a focus on neuropathic mechanisms rather than inflammatory pain.
Mirogabalin Besylate works through:
Selective binding to the α2δ-1 subunit of voltage-gated calcium channels in the central nervous system
Reducing the release of excitatory neurotransmitters such as glutamate and substance P
Modulating hyperactive nerve signals that cause neuropathic pain
Providing pain relief while minimizing sedation and other central nervous system adverse effects compared to other gabapentinoids
By targeting nerve hyperexcitability, Miraba effectively diminishes abnormal pain signaling without altering normal sensory perception.
Starting dose: 5 mg orally once daily
The dose may be titrated gradually based on efficacy and tolerability, typically up to 15–20 mg daily in divided doses
Tablets should be swallowed whole with water, and can be taken with or without food
Dose adjustments may be necessary in renal impairment or elderly patients
Therapy should be initiated and titrated under medical supervision to minimize side effects
Reduces chronic neuropathic pain effectively
Improves sleep quality and daily functioning in patients with nerve pain
Potentially lower incidence of dizziness, somnolence, or weight gain compared to older gabapentinoids
Can be used in long-term pain management strategies for peripheral neuropathy
Oral administration allows convenient and precise dosing
Use cautiously in patients with renal impairment, adjusting dose as necessary
Avoid abrupt discontinuation to reduce the risk of withdrawal symptoms
May interact with other CNS depressants; monitor for excessive sedation
Not recommended during pregnancy or breastfeeding unless clearly indicated
Monitor for allergic reactions or unusual neurological symptoms
Common side effects may include:
Dizziness or drowsiness
Headache
Nausea or vomiting
Peripheral edema
Rare side effects may include:
Confusion, blurred vision
Allergic reactions such as rash or itching
Severe sedation or balance disturbances
Most side effects are mild and transient, with careful titration reducing the risk of adverse effects.
Store in a cool, dry place below 30°C
Protect from light and moisture
Keep out of reach of children
Login Or Registerto submit your questions to seller
No none asked to seller yet